Publisher
Springer Berlin Heidelberg
Reference17 articles.
1. Bois A du, Lück HJ, Meier W et al (2003) A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer. J Natl Cancer Inst 95:1320–1329
2. Bordi C (1999) Gastric carcinoids. Ital J Gastroenterol Hepatol 31(Suppl 2):94–97
3. Chan D, Bergsland EK, Chan JA, Gadgil R, Halfdanarson TR, Hornbacker K, Kelly V, Kunz PL, McGarrah PW, Raj NP et al (2019) Temozolomide in grade III neuroendocrine neoplasms (G3 NENs): a multicenter retrospective review. J Clin Oncol 37:321
4. Delle Fave G, O‘Toole D, Sundin A, Taal B, Ferolla P, Ramage JK, Ferone D, Ito T, Weber W, Zheng-Pei Z, De Herder WW, Pascher A, Ruszniewski P, Vienna Consensus Conference participants (2016) ENETS consensus guidelines update for gastroduodenal neuroendocrine neoplasms. Neuroendocrinology. 103(2):119–124. https://doi.org/10.1159/000443168. Epub 2016 Jan 19. PMID: 26784901
5. Klöppel G (2003) Vom-Karzinoid-zum-neuroendokrinen-Tumor-Klassifizierung-im-Magen-Darm-Trakt-und-Pankreas. Dtsch Arztebl 100(28–29):A-1932/B-1605/C-1513